Fanouriakis, Antonis <br/><br/>
Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.  [electronic resource] 

 -  Seminars in arthritis and rheumatism  Jun 2014 
 - 751-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-866X 
<br/><br/><label>Standard No.: </label>10.1016/j.semarthrit.2013.11.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Adult<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Azathioprine--therapeutic use<br/>Comorbidity<br/>Female<br/>Glatiramer Acetate<br/>Greece--epidemiology<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Immunologic Factors--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon-beta--therapeutic use<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Multiple Sclerosis--drug therapy<br/>Natalizumab<br/>Peptides--therapeutic use<br/>Prevalence<br/>Rituximab